GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1151 - 1175** of **4050** in total

« First

‹ Prev

…

43

44

45

46

47

48

49

50

51

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	15	mild	G22768VO	93
IgG	Patient 2	24	mild	G22768VO	96
IgM	Patient 2	15	mild	G22768VO	464
IgM	Patient 2	24	mild	G22768VO	489
IgM	Patient 1	6	moderate	G22768VO	47
IgA	Patient 2	3	mild	G22768VO	1272
IgG	Patient 2	3	mild	G22768VO	122
IgM	Patient 2	3	mild	G22768VO	679
IgA	Patient 3	-180	mild	G22768VO	272
IgA	Patient 3	11	mild	G22768VO	443
IgG	Patient 3	-180	mild	G22768VO	44
IgM	Patient 3	-180	mild	G22768VO	92
IgA	Patient 3	4	mild	G22768VO	461
IgG	Patient 3	11	mild	G22768VO	49
IgG	Patient 3	4	mild	G22768VO	46
IgM	Patient 3	11	mild	G22768VO	196
IgM	Patient 3	4	mild	G22768VO	194
IgA	Patient 4	12	mild	G22768VO	351
IgG	Patient 4	12	mild	G22768VO	61
IgM	Patient 4	12	mild	G22768VO	139
IgA	Patient 1	10	moderate	G24432YB	352
IgA	Patient 1	22	moderate	G24432YB	297
IgA	Patient 1	6	moderate	G24432YB	279
IgG	Patient 1	10	moderate	G24432YB	21
IgG	Patient 1	22	moderate	G24432YB	21